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Abstract
Capnocytophaga canimorsus, a commensal bacterium of the canine oral flora, has been repeatedly isolated since 1976 from
severe human infections transmitted by dog bites. Here, we show that C. canimorsus exhibits robust growth when it is in
direct contact with mammalian cells, including phagocytes. This property was found to be dependent on a surface-exposed
sialidase allowing C. canimorsus to utilize internal aminosugars of glycan chains from host cell glycoproteins. Although
sialidase probably evolved to sustain commensalism, by releasing carbohydrates from mucosal surfaces, it also contributed
to bacterial persistence in a murine infection model: the wild type, but not the sialidase-deficient mutant, grew and
persisted, both when infected singly or in competition. This study reveals an example of pathogenic bacteria feeding on
mammalian cells, including phagocytes by deglycosylation of host glycans, and it illustrates how the adaptation of a
commensal to its ecological niche in the host, here the dog’s oral cavity, contributes to being a potential pathogen.
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Introduction
Capnocytophaga canimorsus (formerly Centers for Disease Control
group DF-2) has been rarely but regularly isolated from dog or cat
bite infections since its discovery in 1976 [1,2]. C. canimorsus is a
thin Gram-negative rod, found in the normal oral flora of dogs
and cats. Clinical infections by C. canimorsus generally appear as
fulminant septicemia, peripheral gangrene or meningitis [3,4].
Splenectomy, alcohol abuse and immunosuppression have been
associated with a number of cases, but more than 40% of the
patients have no obvious risk factor [5]. Capnocytophaga belongs to
the family of Flavobacteriaceae in the phylum of Bacteroidetes, which is
taxonomically remote from Proteobacteria. The family of
Bacteroidaceae contains many commensals of the mammalian
intestinal system such as Bacteroides thetaiotaomicron and Bacteroides
fragilis [6]. The family of Flavobacteriaceae includes a variety of
environmental and marine bacteria, among which Flavobacterium
johnsoniae is a common soil and freshwater bacterium studied for its
gliding motility [7]. There are only a few examples of pathogenic
bacteria belonging to this family. These are Flavobacterium
psychrophilum, the causative agent of cold water disease in salmonid
fish [8], Ornithobacterium rhinotracheale, a bacterial pathogen known
for causing respiratory disease in poultry [9], and Riemerella
anatipestifer which causes ‘‘duckling disease’’ in waterfowl and
turkeys [10,11]. The genus Capnocytophaga includes seven species
found in normal human oral flora and C. canimorsus found in the
normal flora of dogs and cats. More than 160 cases of C. canimorsus
infections have been reported so far [12] but very few studies have
addressed the molecular mechanisms of C. canimorsus pathogenesis.
Recently, we showed that C. canimorsus 5 (Cc5) resists phagocytosis
by macrophage cell line [13,14]. We also showed that although C.
canimorsus does not affect the viability of murine or human
macrophages, it does not elicit proinflammatory cytokines and it
even blocks the proinflammatory response to the LPS from
enterobacteria [13]. In the course of such experiments, Cc5
exhibited robust growth, although it is usually considered
fastidious for growth. In the present study, we show that a
surface-localized sialidase plays a key role in initiating an extensive
deglycosylation process of host cell glycan structures and that this
feeding mechanism serves as a basis for growth and persistence of
C. canimorsus in vivo.
Results
Growth of C. canimorsus 5 requires direct contact with
cells
When inoculated at a multiplicity of infection (moi) of 20 to
J774.1 murine macrophages cultured in complete RPMI (cRPMI),
which includes 10% fetal bovine serum (FBS), Cc5 multiplied
about 100-fold during the 24 h of infection (Fig. 1A). This
observation could be repeated with non-phagocytic human
epithelial HeLa cells and with canine epithelial MDCK kidney
cells (Fig. 1B). Surprisingly, growth was abolished when J774.1
macrophages were omitted and moreover, Cc5 was unable to grow
in a transwell system, indicating that direct contact is required for
bacterial growth (Fig. 1B). This implies that Cc5 may take
advantage of some nutrient that is present on the host cell surface.
Notably, Cc5 did not adhere tightly to cells and was not
internalized (data not shown). We generated a transposon (Tn)
mutant library using Tn4351 from B. fragilis [15,16] and isolated a
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grew normally on blood agar plates. Wild type (wt) and mutant
bacteria grew equally well in serum enriched heart infusion
medium (Fig. 1C). Impaired growth of this Tn mutant was not due
to an increased phagocytic uptake by J774.1 since addition of
cytochalasin D had little effect on bacterial growth (Fig. 1B).
Surface-localized sialidase is required for the growth of
Cc5 in contact with cells
The transposon inserted at codon 77 within a gene encoding a
protein with similarity to bacterial sialidase, glycosylhydrolase that
cleaves terminal sialic acid from glycoconjugates (Fig. 2A). The
mutated gene, designated siaC, was found to be located
downstream of genes encoding a predicted transcriptional
regulator and a putative N-acyl-glucosamine epimerase (accession
number: EU329392). The first gene downstream was found to
start 148 bp further from the siaC stop codon (Fig. 2B). To exclude
any polar effects of the Tn integration, we tested whether the
downstream gene was transcriptionally linked to siaC. Total RNA
was isolated from wt Cc5, reverse transcribed using two different
primers annealing either at the end of siaC (5132) or at the end of
the downstream gene (5129) and the cDNA was amplified by
PCR. As shown in Fig 2C, even though transcripts were present
for both genes separately, no transcript spanned siaC and the
downstream gene. This result indicates that siaC is not transcrip-
tionally linked to the downstream gene.
While intact Cc5 bacteria cleaved 29-(4-Methylumbelliferyl)-a-
D-N-acetylneuraminic acid (MUAN), the Tn mutant could not,
indicating that the mutated gene does indeed encode a sialidase
(Fig. 3A). We engineered an expression shuttle vector by taking
advantage of a cryptic plasmid isolated from another strain of C.
canimorsus and the promoter of an insertion sequence from B. fragilis
[16]. We constructed plasmids encoding full length (FL) SiaC, a
variant deprived of the 21 N-terminal residues, predicted to be a
signal peptide (D1–21), and a catalytic mutant (Y488C). Sialidase
activity (Fig. 3A) and growth in the presence of J774.1 cells
(Fig. 3B) was restored by introducing in trans siaCFL, but not siaCD1–
21. Sialidase activity was not restored to wt levels by siaCY488C, but
it was still significant (Fig. 3A), suggesting that this residual activity
might account for elevated growth in comparison to the siaC
Figure 1. Growth of C. canimorsus 5 is dependent on cell contact. (A) Viable counts of 2610
6 Cc5 after 24 h in presence of J774.1 macrophages
in RPMI supplemented with 10% FBS (moi=20) (black) or in RPMI with FBS without cells (grey) and in a transwell system preventing physical contact
between bacteria and macrophages in RPMI with FBS (white). (B) Viable counts of Cc5 and Tn mutant after 24 h culture with macrophages in RPMI
and FBS (black), with macrophages in RPMI and FBS in addition of cytochalasin D (grey), with HeLa cells (light grey) and MDCK cells in DMEM and FBS
(white). The grey dotted line represents the bacterial number inoculated. The difference is statistically significant between Cc5 and Tn mutant (2-
tailed unpaired Student’s t test p,0.05) in 3 or more experiments. (C) Growth curve of wt Cc5 (triangles) and Tn mutant (squares) in heart infusion
broth (HIB) supplemented with 10% FBS, represented as the mean of 3 or more experiments with the error bars showing the s.d.
doi:10.1371/journal.ppat.1000164.g001
Author Summary
Capnocytophaga canimorsus is a commensal bacterium of
dogs/cats oral flora, which causes rare but severe
infections in humans that have been bitten or simply
licked by a dog/cat. Fulminant septicemia and peripheral
gangrene are most common symptoms. Although sple-
nectomy has been identified as a predisposing factor,
some 40% of the patients have no immunosuppression
history. C. canimorsus belongs to the phylum Bacteroidetes,
which includes many commensals of the human gut flora
but few pathogens. C. canimorsus has been shown
previously to be immunosuppressive and to resist
phagocytosis by macrophages. Here, we show that this
bacterium feeds on surface-exposed glycoproteins from
cultured mammalian cells. This property, which was found
to depend on a bacterial surface-exposed sialidase,
suggests that in its natural niche—the dog’s oral
cavity—C. canimorsus may feed on the dog’s mucosal
cells. Moreover, we found that C. canimorsus also feeds on
phagocytes and that sialidase contributes to persistence
and virulence in a mouse infection model. Thus, by
adapting to its ecological niche, C. canimorsus also
developed the potential to persist within the tissues of
an infected host. This observation nicely illustrates how
commensalism and pathogenesis are two faces of the
same coin.
Capnocytophaga canimorsus Sialidase
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SiaCY488C were found to be associated with the outer membrane
(Fig. 3C), whereas SiaCD1–21 was only detected in total cells
(Fig. 3B). Indirect immunofluorescence using polyclonal anti-SiaC
serum on paraformaldehyde fixed but unpermeabilized bacteria
confirmed that SiaC is exposed on the bacterial surface unless the
signal peptide is removed (Fig. 3D). Although it is surface exposed,
no SiaC could be detected in the supernatant of infected J774.1
cultures, indicating that it is tightly associated with the outer
membrane (Fig. 3C). Hence, surface-localized sialidase is required
for growth of Cc5 at the expense of mammalian cells.
Growth is sustained by N-acetyl glucosamine (GlcNAc)
and N-acetyl galactosamine (GalNAc) but not by sialic
acids
Since sialidases cleave terminal sialic acid from glycoconjugates,
we first tested whether the addition of sialic acids could restore
growth of siaC. Addition of neither sialic acid (Neu5Ac, N-Acetyl-
2,3-dehydro-2-deoxyneuraminic acid) nor its activated form
(CMP-Neu5Ac, Cytidine-59-monophospho-N-acetylneuraminic
acid) restored growth of siaC in presence of J774.1. In contrast,
growth could be restored by the addition of purified recombinant
SiaC or neuraminidase/sialidase NanH from Clostridium perfringens
to the culture medium, but not by the addition of the catalytically
inactive SiaCY488C (Fig. 4A). This suggested that removal of
terminal sialic acids from glycoconjugates is required to make
other carbohydrates accessible. Indeed, N-acetyl glucosamine
(GlcNAc) and N-acetyl galactosamine (GalNAc), common carbo-
hydrate moieties of glycoconjugates, allowed growth of siaC in the
presence of macrophages (Fig. 4B). Notably, addition of glucose
(Glc), galactose (Gal), mannose (Man) or sialyl-lactose (N-
acetylneuraminosyl-D-lactose) could not restore growth of siaC
bacteria (Fig. 4C). As galactose (Gal) is a common sugar preceding
GlcNAc in glycan molecules, we next tested addition of N-acetyl
lactosamine (LacNAc), a disaccharide consisting of b-D-Gal
b(1R4) GlcNAc. LacNAc also restored the growth defect of siaC
indicating the presence of an active b-galactosidase releasing
monosaccharides Gal and GlcNAc in wt and siaC Cc5 (Fig. 4B).
Figure 2. Identification of the Tn integration site and analysis of mRNA present in wt C. canimorsus 5. (A) Amino acid sequence of the C.
canimorsus sialidase showing the signal peptide (italics) and the BNR/asp repeats (Ser/Thr-X-Asp-X-Gly-X-Thr-Trp/Phe) of bacterial sialidases (boxed).
Domain predictions were analyzed by InterProScan [42]. The residues conserved in sialidases at the C-terminus are underlined and the tyrosine 488 is
bold [43]. The Tn4351 integration site in SiaC at amino acid 77 is indicated, boxed in grey and bold. (B) Genetic locus of the sialidase gene (siaC)
including its upstream genes, gntR-like gene (CAPCA_MM1) and putative N-acyl-glucosamine epimerase encoding gene (CAPCA_MM2); and
downstream coding sequence (CAPCA_MM3). (C) Reverse transcription performed on total RNA with specific primers (5129 or 5132) followed by PCR
to identify transcripts present in wt Cc5 (cDNA). PCR reactions were also performed using genomic DNA (gDNA) as template instead of cDNA as a
positive control. As a control, reverse transcription was performed without reverse transcriptase in a parallel assay and used as template for the
subsequent PCR reaction (-RT).
doi:10.1371/journal.ppat.1000164.g002
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surfaces
J774.1 macrophages were incubated with either wt or siaC
bacteria and thereafter analyzed for lectin binding to investigate
desialyation process on the macrophage cell surface. We used
Sambucus nigra agglutinin (SNA), which recognizes terminal sialic
acids (2- 6 or 2- 3) linked to Gal or to GalNAc, and peanut
agglutinin (PNA), a lectin specific for Gal (b 1–3) GalNAc, a
disaccharide often forming the core unit of O-linked glycoconju-
gates (Fig. 5A). As shown in Fig. 5B, wt bacteria greatly reduced
the amount of sialic acids (SNA panel) and Gal (b 1–3) GalNAc
(PNA panel) at the cell surface, while siaC bacteria had no effect on
glycans masked by sialic acids. When cells were treated
simultaneously with purified SiaC and siaC bacteria, neither sialic
acid nor Gal (b 1–3) GalNAc were detected, indicating that siaC
bacteria are still proficient in extensive deglycosylation of exposed
glycans chains. The same deglycosylation of cell surfaces was
observed when HeLa epithelial cells were used (Fig. 5C).
Sialidase inhibitor N-Acetyl-2,3-dehydro-2-
deoxyneuraminic acid (Neu5Ac2en) can inhibit growth of
Cc5
As bacterial and viral sialidases can share common ASP boxes
that interact with sialic acid, we postulated that common sialidase
inhibitor might have sufficient specificity for the active site in SiaC
to inhibit growth of Cc5 wt bacteria in presence of cells. We tested
the anhydro sialate derivative Neu5Ac2en, which is known to
inhibit many viral and bacterial neuraminidases [17,18]. Approx-
imately 150 cfu/ml of wt Cc5 were inoculated to a culture of
J774.1 macrophages in the presence of 1mM Neu5Ac2en and
growth was monitored after 2, 6, 10 and 24 h (Fig. 6A). Between 2
and 24 h post infection, counts of wt Cc5 were significantly
reduced to values close to the siaC mutant (Fig. 6B). These data
indicate that Neu5Ac2en has affinity for the active site of SiaC and
restricts the growth of Cc5 in the presence of J774.1 cells.
Cc5 but not siaC is able to persist in murine tissue cages
To test whether sialidase could play a role during C. canimorsus
systemic infection, we selected a murine tissue cage infection
model [19]. Around 10
7 cfu of wt or siaC Cc5 bacteria were
injected directly into Teflon cages, which had been subcutaneously
implanted in C57BL/6 mice. Colony forming units (cfu) counts of
wt decreased on day 2 and 5. However, on day 9 they increased by
1 to 3 logs in 4 out of 5 mice, and were able to persist in 3 of 5
mice after 27 days post infection with more than 10
7 bacteria per
ml fluid. The siaC bacteria were undetectable after the second day
in 5 out of 5 infected mice (Fig. 7A). After infection, the total
number of leukocytes in tissue cage fluid (1.8610
4 +/2 1.3610
4
leukocytes/ml, mean +/2 standard deviation, s.d.) did not
Figure 3. Surface localized sialidase is required for growth. (A) Sialidase activity of intact bacteria, measured with the substrate MUAN as the
mean of triplicate measurements and s.d. of a representative experiment. (B) Viable counts after challenge with 2610
6 Cc5 (black), siaC (light grey) or
siaC complemented with plasmids containing siaCFL, siaCD1–21 and siaCY488C after 24 h in presence of J774.1 with the grey dotted line indicating the
bacterial number inoculated. Sialidase was detected by immunoblotting with a polyclonal antibody against SiaC in total cells (TC). (C) Outer
membrane protein fractions (OMP), cell free supernatants (SN) of the J774.1 cultures shown in (B) including as control TC of Cc5 were analyzed by
immunoblotting for the presence of SiaC. (D) Surface localization of SiaC was tested by immunofluorescence on paraformaldehyde fixed but not
permeabilized bacteria using anti-SiaC followed by anti- rabbit IgG conjugated to FITC.
doi:10.1371/journal.ppat.1000164.g003
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suggesting that Cc5 infection did not lead to strong leukocyte
recruitment. This was in agreement with the suppression of
inflammation, which we previously reported [13]. In mixed
infections, the competitive index of siaC bacteria was 9.7610
24,
5.8610
27 and 4.7610
27 on day 5, 9 and 14, respectively. As
Figure 4. Aminosugars but not sialic acids sustain growth of C. canimorsus. Viable counts after challenge with 2610
6 wt Cc5 (black) or siaC
(grey) grown for 24 h with J774.1 in cRPMI (control) or in the same condition with the addition of Neu5Ac, Neu5Ac- CMP, 12.5 ng/ml enzyme SiaCFL,
SiaCY488C or NanH from C. perfringens (A) or with the addition of GalNAc, GlcNAc or LacNAc (B) or with the addition of mannose, galactose, glucose or
sialyl-lactose (C). Mean values from 3 or more experiments and s.d. are shown including statistical difference between wt Cc5 and siaC with * p,0.05,
** p,0.01 and *** p,0.001 for each pair of columns (2-tailed unpaired Student’s t test). The grey dotted line indicates the bacterial number
inoculated.
doi:10.1371/journal.ppat.1000164.g004
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were infected by both strains developed a persistent infection
(Fig. 7B).
The fluid from uninfected control cages was collected and the
leukocytes and liquid were tested separately for their capacity to
sustain growth of Cc5. Interestingly, wt Cc5 did not grow in the
presence of the cell-free liquid (data not shown) but they grew in
presence of leukocytes whereas siaC bacteria did not (Fig. 7C).
Both strains grew equally well in heart infusion broth supple-
mented with 10% FBS, indicating a similar fitness in vitro (Fig. 1C).
Mixed cultures in heart infusion broth supplemented with 10%
FBS showed comparable growth of wt and siaC bacteria. Both
strains reached 10
6 cfu/ml after 24 h (Fig. 7D).
Our data from mixed infection in mice suggest that there is no
cross-feeding of nutrients between wt and siaC Cc5 (Fig. 7B). We
thus tested whether there would be cross-feeding between wt and
siaC bacteria when inoculated to J774.1 cultures. When wt and
siaC were inoculated together at 1:1 ratio to J774.1 cells, wt Cc5
Figure 5. C. canimorsus desialylates macrophage and epithelial cell surfaces. (A) The targets of the lectins used in this study are
schematically represented (adapted from [44]). Surface carbohydrates of J774.1 macrophages (B) or HeLa epithelial cells (C) were analyzed by lectin
binding after 2 h of infection with 4610
7 wt (Cc5)o rsiaC bacteria. Cells were fixed with paraformaldehyde and incubated for 1 h with lectin SNA,
which recognizes terminal sialic acids (2- 6 or 2- 3) linked to Gal or to GalNAc or PNA that binds to the disaccharide Gal 1–3 GalNAc only after removal
of terminal sialic acids. SiaC was added to cells alone or with siaC bacteria at 100 ng/ml. Biotinylated lectins were visualized by FITC conjugated
streptavidin.
doi:10.1371/journal.ppat.1000164.g005
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8 cfu/ml while siaC bacteria only reached 3610
6 cfu/
ml 24 h post infection (Fig. 7E).
Taken together, these results demonstrate that SiaC plays an
essential role in allowing persistence of wt Cc5 in this tissue cage
model and that clearance of siaC bacteria is not due to a growth
defect per se but to an altered interaction of the mutant with the
host. Since sialidase is surface-exposed, one could consider the
possibility that it alters the susceptibility to complement. Hence,
we checked the susceptibility of wt and siaC Cc5 to mouse
complement and found no difference (data not shown). It is also
very unlikely that siaC bacteria have an increased sensitivity to
killing by mouse leukocytes. Indeed, we tested phagocytosis and
killing by human polymorphonuclear leukocytes and found no
difference between wt and siaC bacteria (Manuscript in prepara-
tion). Hence, we conclude that the role of sialidase in infected mice
is essentially nutritional.
Discussion
Sialic acids are a family of nine carbon acid sugars among which
Neu5Ac is one of the most widespread variants. Sialic acids are
predominantly found at the terminal position of cell-surface and
secreted eukaryotic glycan structures and are involved in many
physiological processes including binding to microbes and down-
regulation of innate immunity [20–22]. Therefore it is not
surprising that sialic acids play a role in a variety of host microbe
interactions. Several pathogens have evolved ways to expose sialic
acid on their surface and hence to escape complement killing and
opsonization by mimicry. Sialic acids are incorporated into
capsules by E. coli K1 [23], Group B Streptococci [24], Serogroups
B, C, W135 and Y Neisseria meningitidis [25]. The lipooligosacchar-
ide of Neisseria gonorrhoeae, Neisseria meningitidis and Haemophilus
influenzae are also sialylated [26]. In this case, a bacterial
sialyltransferase uses CMP-Neu5Ac from the host as a substrate
[26]. Sialic acids can also be synthesized from lactate by Neisseria
itself, demonstrating a close link between metabolism and evasion
of innate immune defenses [27].
Besides molecular mimicry, many microbes can utilize sialic
acids as a source of carbon and nitrogen like E. coli K1, H.
influenzae or C. perfringens [28]. Their metabolism comprises a
permease for uptake and a neuraminiate lyase for conversion to N-
acetyl mannosamine, which is either degraded or used in sialic
acid biosynthesis. A number of commensal and pathogenic
bacteria are also endowed with a sialidase, a glycosylhydrolase
that cleaves sialic acid from sialo-glycoconjugates. Bacterial
sialidases have been thought since a long time to contribute to
virulence in bacteria that colonize mucosal surfaces such as Vibrio
cholerae, Streptococcus pneumoniae, group B streptococci, C. perfringens and
B. fragilis but the exact role of sialidase on virulence remains
controversial [29]. Recently, it was shown that a sialidase is
involved in the formation of Pseudomonas aeruginosa biofilms and
hence contributes to colonization of the lungs during the initial
stages of infection in cystic fibrosis patients [30]. In S. pneumoniae, a
sialidase initiates an extensive deglycosylation of different host
proteins, including IgA1 and human secretory component [31].
Furthermore, the sequential action of exoglycosidases sustains
growth of S. pneumoniae on human a-1 acid glycoprotein, though
growth is not as robust as on sucrose and lactose. Although the
genetic analysis suggests that sugars from the glycan chain would
sustain growth, this has not been shown directly [32].
In the present study, which is among the very first on the
pathogenesis mechanisms of C. canimorsus, we demonstrate that a
sialidase allows C. canimorsus to feed on glycan chains from
glycoproteins. The role of sialidase is not to supply sialic acid since
growth of the sialidase-deficient mutant could not be restored by
adding sialic acid to the culture medium. Thus, we have a situation
similar to that of S. pneumoniae: the role of sialidase is to provide
access to masked sugars of surface-exposed glycoproteins. Growth
of the sialidase-deficient mutant could be restored by amino sugars
like GalNAc, GlcNAc and LacNAc but not by glucose, galactose,
mannose or sialyl-lactose, indicating that the nutritional require-
ments of C. canimorsus are very different from those of S. pneumoniae.
Our study thus confirms the importance of a sialidase to initiate
a deglycosylation process for bacterial metabolism. Moreover, in
Figure 6. The sialidase inhibitor Neu5Ac2en decreases growth of wt C. canimorsus 5 in presence of macrophages. (A) Viable counts of
approximately 150 bacteria grown in cRPMI in the presence of J774.1 cells for 2, 6, 10 and 24 h: siaC bacteria (light grey); wt Cc5 bacteria with 1mM
Neu5Ac2en (grey, dotted line); wt Cc5 in the absence of inhibitor (black). Mean values from 4 experiments and s.d. are shown including statistical
difference between Cc5 and siaC in grey or between Cc5 and Cc5 treated with Neu5Ac2en in black with * p,0.05, ** p,0.01 and *** p,0.001 (2-
tailed unpaired Student’s t test). (B) Data from viable counts (mean) shown in (A) is represented as the fold difference compared to wt Cc5. The
statistical difference is depicted from (a) with * p,0.05, ** p,0.01 and *** p,0.001.
doi:10.1371/journal.ppat.1000164.g006
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on glycoproteins exposed at the surface of epithelial cells or even of
macrophages, in spite of the fact that they do not adhere to these
cells. The observation of extracellular bacteria specifically feeding
on the surface of epithelial cells is not unprecedented. It has been
described for B. thetaiotaomicron, a major commensal from the
intestine, which feeds on fucosylated intestinal cells. Colonization
by B. thetaiotaomicron even triggers the appearance of fucosyltrans-
ferase and fucosylated glycan expression [33]. Recent studies
showed that host acquired fucose is incorporated by B. fragilis into
capsular polysaccharide or glycoproteins, which in turn provides a
survival advantage in the mammalian intestinal ecosystem [34]. As
for C. canimorsus, it is likely that the capacity to feed on HeLa cells
reflects the adaptation to feed on buccal epithelial cells.
Sialidase, which is pivotal in this feeding process, is surface
localized and this surface localization is a prerequisite for
unmasking glycan structures. It is not common to find enzymes
anchored into the outer membrane, facing the outside of Gram-
negative bacteria but there are examples like pullulanase a 116-
kDa isoamylase of Klebsiella oxytoca [35]. Not surprisingly, SiaC is
endowed with an N-terminal signal sequence, which turned out to
be critical for its targeting. Sialidase thus crosses the cytoplasmic
membrane via the Sec pathway but we have at present no
explanation on how it crosses the outer membrane and remains
anchored. It is probably not by a C. canimorsus specific mechanism
since sialidase appeared to be also surface-exposed when expressed
in E. coli (unpublished data). Sialidase could be a lipoprotein, like
pullulanase. Alternatively, sialidase could be a surface-anchored
Figure 7. The sialidase mutant is hypo-virulent in a tissue cage mouse infection model. Tissue cages were implanted in C57BL/6 mice and
infected with 10
7 Cc5 wt and siaC bacteria (n=5) singly (A) or in competition (B). Bacteria were counted in tissue cage fluid (TCF) during 27 days
(Cc5=black circles; siaC=open circles). Individual values are shown; horizontal lines indicate the median value of each group. The black dotted line is
the detection limit of 20 bacteria per ml TCF. (A) Cfu numbers between groups were significantly different on days 2, 5 and 9 with p,0.01 and on
days 14 and 27 with p,0.05 (Mann Whitney test). (B) 10
7 cfu Cc5 and erythromycin resistant siaC were inoculated at a 1:1 ratio. Bacterial numbers
were analyzed for 27 days (n=5). Viable counts between wt and siaC were significantly different on day 2, 5 and 9 with p,0.01 and on day 14 with
p,0.05. (C) Ex vivo isolated leukocytes were resuspended in serum free RPMI and inoculated at a moi of 20 (2610
6 bacteria) or 0.2 (2610
4 bacteria)
indicated with grey dotted lines and bacterial viable count was monitored after 24 h. Values represent the mean using TCF cells from 3 uninfected
mice. TCF leukocytes consist of 68% +/2 4.8% polymorphonuclear neutrophils (PMNs), 18% +/2 3.2% monocytes and 9.1% +/2 3.7% macrophages.
Wt and siaC numbers were significantly different with p,0.05 (*) and p,0.001 (**) using 2-tailed unpaired student’s t test. (D) In vitro, Cc5 and siaC
were tested in heart infusion broth with FBS inoculated at a 1:1 ratio with approximately 100 bacteria total and bacterial growth was monitored for 2,
6, 10 and 24 h. (E) Viable counts after challenge with 2610
6 (grey dotted line) Cc5 (black) or siaC (grey) grown for 24 h with J774.1 in cRPMI singly
(control) or at a 1:1 ratio (cross-feeding).
doi:10.1371/journal.ppat.1000164.g007
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However, the fact that the C-terminus of sialidase is not involved
in the surface localization (unpublished data) argues against this
hypothesis. Work in progress tries to address the question of how
sialidase is anchored in the outer membrane.
Unlike what is observed with pullulanase, our data indicate that
extremely little sialidase is released from C. canimorsus. This
observation is in perfect agreement with the fact that C. canimorsus
needs to be in direct contact with cells to feed on them. It also
makes sense in the context of the mouth commensal microflora.
Indeed, the oral cavity is occupied by some 500 different bacterial
strains [37,38], creating a fierce competition for nutrition. The fact
that C. canimorsus does not release this enzyme suggests that C.
canimorsus maximizes the benefit of sialidase by not sharing this
fitness factor with competing bacteria. In agreement with this
hypothesis, there is no cross-feeding when wt and siaC Cc5 bacteria
are inoculated together in the presence of macrophages. This
implies that wt C. canimorsus must be extremely efficient in
capturing the aminosugars that it extracts from the surface of cells
and we hypothesize that C. canimorsus has dedicated high affinity
transporters for these in its outer membrane.
Extracellular C. canimorsus replicated very efficiently not only
when they were in direct contact with HeLa cells but also with
J774.1 macrophages. Thus, C. canimorsus not only resists phago-
cytosis by cultured macrophages [13,14], but they even take
advantage of macrophages whose normal function is to engulf and
kill microbes. To our knowledge, this is the very first report of a
pathogen that can feed on phagocytic cells. This observation
suggests that sialidase could contribute to virulence. We used a
mouse tissue cage model in which the readout is bacterial
persistence and we observed a dramatic difference in persistence
between wt and sialidase-deficient C. canimorsus. Even more, we
gained evidence that in vivo, C. canimorsus also feeds on phagocytes.
These observations confirm our hypothesis that sialidase contrib-
utes to virulence, at least in the mouse model. It seems reasonable
to extrapolate that it also plays a critical role during human
infections. We would however be reluctant to call sialidase a
virulence factor since it most probably evolved as a fitness factor
for commensalism in the dog’s mouth. Nevertheless, the mouse
experiment shows that it may become a persistence factor if C.
canimorsus is introduced in the tissues from another host. Our study
thus shows once again the link between metabolism and virulence,
as already well documented in studies on Salmonella [39], Listeria
[40] and Neisseria [27]. However, unlike what was seen with
Salmonella, there seem to be no or very little redundancy in the in
vivo metabolism of C. canimorsus since the loss of sialidase had
dramatic consequences on growth. It is interesting to observe that
nutrition in vivo may be quite specific in spite of a very rich
nutritional environment. Indeed, only GlcNAc and GalNAc could
rescue growth while glucose had no effect and galactose was even
deleterious. This difference could result from the fact that unlike
Salmonella, C. canimorsus is a commensal highly adapted to its niche
and only exceptionally a pathogen. Specialization is probably the
hallmark of a bacterium that is primarily a commensal and only
rarely a pathogen. Finally, C. canimorsus represents one more
example illustrating that the distinction between commensals and
pathogens is illusive. Commensalism and pathogenesis are two
faces of the same coin.
Influenza neuraminidases have been successfully targeted with
chemotherapeutic inhibitors for prophylaxis and treatment [41].
Given the wide prevalence and important role of sialidases in
microbial infections, inhibition of bacterial sialidases could also
provide a mechanism to prevent bacterial spreading during
infections. Here, we observed a significant inhibition of the growth
of C. canimorsus in the presence of macrophages by Neu5Ac2en.
These preliminary data indicate that microbial sialidases could
indeed serve as an attractive drug target to prevent bacterial
dissemination.
Materials and Methods
Bacterial strains and growth conditions
C. canimorsus 5 was routinely grown on Heart Infusion Agar
(HIA; Difco) supplemented with 5% sheep blood (Oxoid) for
2 days at 37uC in presence of 5% CO2. Bacteria were harvested
by gently scraping colonies off the agar surface, washed and
resuspended in PBS. C. canimorsus was also grown in Heart Infusion
Broth (Difco) supplemented with 10% (v/v) fetal bovine serum
(FBS; Invitrogen) for approximately 24 h without shaking in an
37uC incubator with 5% CO2. Selective agents were added at the
following concentrations: erythromycin, 10 mg/ml; cefoxitin,
10 mg/ml; gentamicin, 20 mg/ml; ampicillin, 100 mg/ml.
Cell Culture and Infection
Murine monocyte-macrophage J774A.1 cells (ATCC TIB-67)
were cultured in RPMI 1640 (Invitrogen) supplemented with 10%
(v/v) FBS (Invitrogen), 2 mM L-glutamine and 1 mM sodium
pyruvate. Human epithelial HeLa cells (ATCC CCL-2) and
canine epithelial MDCK kidney cells (ATCC CCL-34) were
grown in DMEM (Invitrogen) with 10% (v/v) FBS. Cells were
seeded in medium without antibiotics at a density of 10
5/cm
2 and
cultured at 37uC in humidified atmosphere containing 5% CO2.
Unless otherwise indicated, infection was performed after 15 h at a
moi of 20 representing 2610
6 bacteria per ml in each well at 37uC.
Monosaccharides and disaccharides (Sigma Aldrich) were
added to 0.1% (w/v) final concentration. Neu5Ac and CMP-
Neu5Ac were added to 0.01% final concentration.
Cc5 was pretreated with 1mM Neu5Ac2en at 37uC for 30 min.
Subsequently, infection of J774.1 was carried out in presence of
1 mM Neu5Ac2en during 24 h.
Arbitrarily Primed PCR
Primers specific to the ends of the transposon and primers of
random sequence that may anneal to chromosomal DNA
sequences in close proximity to the transposon insertions were
used in two rounds of PCR before sequencing. The first round of
amplification was carried out in 50 ml containing 100 ng of
genomic DNA, 1.5 mM MgCl2, 200 mM of primers 59 CA-
GAATTCTGTTGCATTTGCAAGTTG 39 complementary to
Tn4351 and 59ggccacgcgtcgactagtacNNNNNNNNNNacgcc39,
2.5 U of DNA polymerase (DyNAzymeII, Finnzymes), 200 mM
of each dNTP, in 10 mM Tris HCl (pH 8.3) for 6 cycles (94uC for
1 min, 30uC for 1 min, 72uC for 2 min) and 30 cycles (94uC for
1 min, 45uC for 1 min, 72uC for 2 min) and final 10 min at 72uC.
10 ml of PCR product containing random fragments was used as
template in a second round of 30 cycles of amplification (94uC for
30 sec, 45uC for 30 sec, 72uC for 1 min) using primers 59
CAGAATTCTGTTGCATTTGCAAGTTG 39 and 59
GGCCACGCGTCGACTAGTAC 39, from the 59 of the random
primer. PCR products were purified using NucleoSpinH from
Machery Nagel. 20- 50 ng of random sized products were
sequenced using an ABI sequencer. The Tn integration site was
further confirmed by using primers on chromosomal DNA by
sequencing towards the Tn integration site. Primers used were 59
AATTGTTGTAACGATTGTCG 39 or 59 GCGAAGCGT-
TATCCCAAAGC 39 complementary to the siaC sequence in a
sequencing reaction containing 2 mg genomic DNA of siaC,
betaine 0.25 M and BigDye Terminator Ready Reaction (PE
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subsequent 99 cycles (95uC for 30 sec, 50uC for 20 sec, 60uC for
4 min).
RNA isolation and reverse transcription (RT) PCR
Cc5 were grown for 2 days on HIA blood plates. RNA was
isolated from 5610
8 bacteria by a hot phenol/chloroform
extraction method followed by DNase I (Amersham Pharmacia)
treatment (0.5 U/mg RNA) for 2 h at 37uC. RNA was further
cleaned by using a RNeasy kit (Quiagen) and stored at 280uC
until use. An additional DNase I digest was introduced with 0.25
U/mg RNA for 15 min at 37uC and stopped by addition of final
2.5 mM EDTA and heat inactivation at 75uC for 10 min.
Subsequent reverse transcription was performed with 50 U
Superscript II/mg RNA in RT buffer (Invitrogen), 10 mM DTT
and 50 mM specific primer (5129: 59 GGGTAATCCG-
CACTTGTCGGG39 or 5132: 59 GTTTAGTTCTTGA-
TAAATTCC 39) for 60 min at 42uC and stopped at 70uC for
10 min. 10% of cDNA preparation or of a preparation made
without addition of reverse transcriptase was subjected to PCR
using following primer combinations: 4130 (59 GGGTAACAA-
CAAAAACCACTG 39)+5129; 4132 (59 TATAAGAA-
TAATTGGTGGGC 39)+5129; 4130+5132. 100 ng of genomic
DNA from Cc5 was used as a positive control of the PCR
reactions.
Construction of complementation and expression
plasmids
Full length siaC was amplified with 59 CATACCATGG-
GAAATCGAATTTTTTATCTT 39 and 59 GTTCTAGA-
GAGTTCTTGATAAATTCCTCAACTG 39 primers and
cloned into the E. coli- C. canimorsus shuttle vector pMM47.A
[16] with NcoI and XbaI, leading to the insertion of a glycine at
position 2 and a C- terminal histidine 66tag in plasmid pMM52
(siaCFL). Forward primer 59 AAAGCCATGGGAAACG-
TAATCGGCGGAGGCG 39 was used with the same reverse
primer to construct pMM50 (siaCD1–21), deleting the first 63 bp of
siaC, but still including methionine and glycine at position 1 and 2,
respectively, and using a C-terminal His 66 tag. The catalytic
mutation in siaC of was introduced by site directed mutagenesis
with an inverse PCR on pMM52, using primers 59 GAAG-
GATTTGGGTGTTCGTGTATGTCG 39 and 59 CGACATA-
CACGAACACCCAAATCCTTC 39 leading to pMM59 (sia-
CY488C). Plasmids derived from pMM47.A contained the cfxA gene
originating from Bacteroides sp. and could be selected in C. canimorsus
with 10 mg/ml cefoxitin [16]. The beta-lactamase also present on
pMM47.A was used as a selection marker in E. coli.
The cDNAs encoding SiaCD1–21 (pHS2) were subsequently
amplified using 59 GGAATTCCATATGAACGTAATCGGCG-
GAGGC 39 plus 59 CGCGGATCCCTAGTTCTTGA-
TAAATTCCTC 39 and cloned into the expression vector
pET15b(+) (Novagen). Plasmid pHS3 encoding SiaCD1–21,Y488C
was constructed by site directed mutagenesis on template pHS2
using the same primers as described for pMM59. All constructs
were sequenced with an ABI sequencer. The sequence of SiaC was
deposited at GenBank (accession number: EU329392).
Purification of recombinant SiaC and immunoblotting
Expression of siaC constructs in E. coli BL21(DE3) was induced
with 0.5 mM isopropyl-b-D-1-thiogalactopyranoside at A600=0.5
for 3 h. Proteins were purified by affinity chromatography using
chelating Sepharose (Pharmacia) charged with NiSO4 according
to the manufacturer’s instructions. Samples were analyzed by
SDS-PAGE by the system of Laemmli, and immunoblotted.
Polyclonal serum from rabbit was generated against recombinant
SiaCD1–21. The antigen was injected at days 0, 14, 28, and 56 with
a final bleeding at day 80 (Laboratoire d’Hormonologie, Marloie,
Belgium).
MUAN hydrolysis
10
7 bacteria were incubated with 0.006% 29-(4-Methylumbelli-
feryl)-a-D-N-acetylneuraminic acid (MUAN) in 0.25 M sodium
acetate pH 7.5 at 37uC for 3 min. Reactions were stopped with
50 mM Na2CO3 pH 9.6 and fluorescence was determined at
445 nm with a Wallac Victor
2 1420 Multilabel counter (Perkin
Elmer).
Outer Membrane Preparation
Bacterial cells resuspended in PBS containing DNase and
RNase (10 mg/ml), were sonicated on ice. Unbroken cells were
removed at 30006 g for 15 min, and total membranes were
collected at 20 0006g for 30 min at 4uC. The membranes were
suspended in PBS and sarcosyl (N-Lauroylsarcosine sodium salt,
Sigma) was added to a final concentration of 1% (v/v). After
incubation on ice for 1 h, membranes were collected at 20 0006g
for 30 min and resuspended in electrophoresis sample buffer and
analyzed by SDS-PAGE by the system of Laemmli.
Immunofluorescence of bacteria
10
7 bacteria were incubated on poly-D-lysine (BD) coated glass
slides for 1 h at 37uC and subsequently fixed with 3%
paraformaldehyde for 15 min. Anti- SiaC polyclonal serum
(1:500) and a FITC conjugated secondary antibody (Goat Anti-
Rabbit IgG, Southern Biotech) was used at 1 mg/ml and
fluorescence was measured with a Leica DMIRE2 microscope.
Pictures were taken with a digital camera (Hamamatsu Photonics)
and analyzed with OpenLab software (version 3.1.2) and Adobe
Photoshop CS3 (version 10.0.1).
Lectin Staining
10
5 J774.1 macrophages or HeLa epithelial cells were seeded on
poly-D-lysine coated slides. Infection was carried out with 4610
7
bacteria for 2 h. Uninfected cells were alternatively treated with
purified recombinant SiaC at 100 ng/ml. Cells were fixed with
3% paraformaldehyde for 15 min. Biotinylated lectins SNA and
PNA (Vector Laboratories) were incubated with cells at 2 mg/ml
and 2.5 mg/ml, respectively, for 1 h. After washing with PBS, cells
were treated with 1 mg/ml fluorescein conjugated streptavidin
(Vector Laboratories) and fluorescence was determined on
mounted slides (Vectashield, Vector Laboratories).
Mice and tissue cage infection model
12 week-old male C57BL/6 mice were maintained under
pathogen-free conditions in the Animal Facility of the Department
of Research, University Hospital Basel. Animal experiments were
performed in accordance with the guidelines of the Swiss
veterinary law. Teflon tissue cages were implanted subcutaneously
in the back of anesthetized mice as previously described [19]. The
cages consisted of closed Teflon cylinders (10 mm diameter,
30 mm length, internal volume 1.84 ml) with 130 regularly spaced
0.2 mm holes. 2 weeks after surgery, 200 ml of bacterial
suspension was injected percutaneously into the cage. Prior to
infection, sterility of the tissue cage was verified. Tissue cage fluid
(TCF) was sampled at day 2, 5, 9, 14 and 27 and examined for
leukocytes and bacterial viable counts. Leukocytes from TCF were
quantified with a Coulter counter (Coulter Electronics) and
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of cytospins and examined under light microscopy. The
percentage of viable leukocytes was assessed by trypan blue
exclusion.
The survival of siaC bacteria in the competition experiment was
compared directly with wt Cc5 in individual animals giving a 1:1
ratio of wt to mutant bacteria. The number of mutant
(erythromycin resistant) and wt bacteria recovered from the
TCF of animals was established by plating to media with and
without erythromycin. The competitive index was calculated as
the (number of mutant/wild-type bacteria recovered from
animals)/(number of mutant/wild-type bacteria in the inoculum).
Statistical analysis
For growth experiments, means and standard deviation (s.d.)
were calculated and statistical significance was evaluated by using
a two- tailed, unpaired Student’s t test. Differences were
determined to be significant when p,0.05. For in vivo experiments,
individual mouse values are shown including the median value of
each group. Mann Whitney test with the post hoc Bonferroni
correction was used for comparison between Cc5 and siaC cfu
numbers during infection.
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